Clinical Trial Update: Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel with or without carboplatin in advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED